Ondine Biomedical has highlighted a paper published in The Journal of Nature/Scientific Reports that nasal antimicrobial photodynamic disinfection therapy (aPDT) effectively inactivated SARS-CoV-2 in the nose of patients with COVID-19.
The paper, from the Sunnybrook Research Institute in Toronto called "Translational feasibility and efficacy of nasal photodynamic disinfection of SARS‑CoV‑2", reports that 90% of patient samples showed decreased viral infectivity, with 70% showing no detectable virus after a single 5-minute treatment.
Singapore-based state-owned fund Temasek is joining Sandbox developer Animoca Brands in a US$100mln funding round, Bloomberg has reported.
Sectors of focus were not disclosed, but both entities have a substantial background in investing in metaverse, NFT and blockchain enterprises.
Chesnara PLC (LSE:CSN), the life and pensions consolidator, ended the first half in a strong cash position – providing the financial firepower to fund its growth and dividend strategy.
The group, which completed two key purchases in the period and is in the process of working on a third, was sitting on a balance of £155.4mln, which it estimates will provide it with £100mln of acquisition currency.
Futura Medical PLC (AIM:FUM, OTC:FAMDF) believes its MED3000 gel is ideally suited to becoming America’s first over-the-counter treatment for erectile dysfunction (ED) after successfully negotiating a US phase III clinical trial.
It hopes to submit a dossier to the Food & Drug Administration (FDA) by the end of next month targeting marketing approval for the product by the first quarter of next year.
Antipa Minerals Ltd (ASX:AZY) has demonstrated the robust financial and technical credentials of a standalone gold mining and processing operation at the Minyari Dome Project in Western Australia with the results of a scoping study.
The study has painted a rosy picture of Minyari, forecasting an initial combined open pit and underground production of 21.4 million tonnes at 1.6 g/t gold for 1.1 million ounces of gold.
Supply@ME Capital PLC (LSE:SYME) reported the exercise of just over 5mln share warrants, and, will issue new shares yielding £3.28mln to the company.
Tlou Energy Ltd (AIM:TLOU, ASX:TOU, BSE:TLOU) announced it will hold its AGM on Tuesday, 18 October.
Redx Pharma PLC (AIM:REDX) told investors that it will present a poster on RXC007 at the forthcoming European Respiratory Society (ERS) International Congress in Barcelona, between September 4 and September 6. It noted that the poster will present preclinical data on the potential benefits of RXC007, Redx's lead fibrosis asset.
Norman Broadbent PLC (AIM:NBB) chief executive Kevin Davidson had purchased 42,119 ordinary shares in the company, at a price of 4.72p.
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) noted that its senior management today presents at the ‘Africa Down Under’ conference being held in Perth, Western Australia.
Base Resources Limited (AIM:BSE, ASX:BSE) similarly told investors that it has presented at the conference.